JPMorgan Chase & Co. Increases Relx (NYSE:RELX) Price Target to GBX 2,840

Relx (NYSE:RELX – Get Rating) had its price target upped by analysts at JPMorgan Chase & Co. from GBX 2,810 ($34.25) to GBX 2,840 ($34.61) in a research report issued to clients and investors on Wednesday, The Fly reports.

RELX has been the topic of a number of other reports. Credit Suisse Group lifted their price target on shares of Relx from GBX 2,800 ($34.13) to GBX 2,860 ($34.86) in a research report on Friday, February 17th. StockNews.com started coverage on shares of Relx in a report on Wednesday, November 30th. They set a “hold” rating on the stock. Barclays lowered shares of Relx from an “overweight” rating to an “equal weight” rating in a report on Tuesday, January 31st. Finally, Morgan Stanley dropped their price objective on shares of Relx from GBX 3,020 ($36.81) to GBX 2,950 ($35.95) in a report on Friday, December 16th.

Relx Price Performance

Shares of NYSE RELX opened at $30.95 on Wednesday. The company’s fifty day moving average is $29.72 and its 200-day moving average is $27.67. Relx has a twelve month low of $23.39 and a twelve month high of $32.24. The company has a debt-to-equity ratio of 1.56, a current ratio of 0.59 and a quick ratio of 0.53.

Institutional Investors Weigh In On Relx

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Resurgent Financial Advisors LLC acquired a new stake in Relx in the 4th quarter valued at $27,000. CoreCap Advisors LLC acquired a new position in shares of Relx during the 2nd quarter worth about $28,000. Pinnacle Bancorp Inc. acquired a new position in shares of Relx during the 3rd quarter worth about $35,000. Allworth Financial LP increased its stake in shares of Relx by 455.3% during the 3rd quarter. Allworth Financial LP now owns 1,455 shares of the technology company’s stock worth $35,000 after purchasing an additional 1,193 shares during the last quarter. Finally, Penserra Capital Management LLC acquired a new position in shares of Relx during the 3rd quarter worth about $36,000. 3.41% of the stock is currently owned by institutional investors and hedge funds.

About Relx

(Get Rating)

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.